|
PARVA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.42530000421826E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.551310E-04 |
| Normal-vs-Stage2 |
4.85490003754308E-09 |
| Normal-vs-Stage3 |
7.32489999766273E-08 |
| Normal-vs-Stage4 |
2.391100E-04 |
| Stage1-vs-Stage2 |
1.039510E-03 |
| Stage1-vs-Stage3 |
2.200500E-02 |
| Stage1-vs-Stage4 |
1.570610E-01 |
| Stage2-vs-Stage3 |
2.463800E-01 |
| Stage2-vs-Stage4 |
2.829800E-01 |
| Stage3-vs-Stage4 |
8.806000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27809999975292E-07 |
| Normal-vs-AfricanAmerican |
1.64754999999461E-05 |
| Normal-vs-Asian |
5.653000E-01 |
| Caucasian-vs-AfricanAmerican |
2.871900E-02 |
| Caucasian-vs-Asian |
5.438600E-01 |
| AfricanAmerican-vs-Asian |
2.432600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12979999800089E-08 |
| Normal-vs-Female |
1.228130E-04 |
| Male-vs-Female |
1.844790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.997400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.9801000000026E-05 |
| Normal-vs-Age(61-80Yrs) |
2.51620002611475E-09 |
| Normal-vs-Age(81-100Yrs) |
1.015000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.708800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.530600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.020360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.687900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.879600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.193400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.692820E-01 |
| Normal-vs-Grade 2 |
4.629100E-04 |
| Normal-vs-Grade 3 |
5.28929999799033E-09 |
| Normal-vs-Grade 4 |
1.65916999999016E-05 |
| Grade 1-vs-Grade 2 |
7.183400E-01 |
| Grade 1-vs-Grade 3 |
1.751600E-01 |
| Grade 1-vs-Grade 4 |
1.916620E-01 |
| Grade 2-vs-Grade 3 |
5.159700E-03 |
| Grade 2-vs-Grade 4 |
3.194000E-02 |
| Grade 3-vs-Grade 4 |
8.792200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.50240000002167E-06 |
| Normal-vs-ccB subtype |
1.000950E-03 |
| ccA subtype-vs-ccB subtype |
4.398200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.58719999996538E-07 |
| Normal-vs-N1 |
7.482400E-02 |
| N0-vs-N1 |
7.360600E-01 |
|
|
